Moreover, the results from the UALCAN database suggested that HSF2 overexpression was significantly correlated with a shorter OS for patients with HCC of different tumor grades and sexes (Supplementary Figure S1A). This evidence concerns the gene HSF2 and hepatocellular carcinoma.